NeuroOne Medical Technologies (NMTC) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NeuroOne Medical Technologies is the larger company by market cap ($9.8 million vs $6.6 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMTC | VNRX |
|---|---|---|
| Share price | $1.08 | $0.2194 |
| Market cap | $9.83M | $6.60M |
| 1-day change | -2.70% | -2.92% |
| YTD return | -76.25% | — |
| 1-year return | -82.69% | — |
| 5-year return | -94.00% | — |
| EPS (TTM) | $-0.99 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.42 | $10.40 |
| 52-week low | $0.962 | $0.217 |
| Distance from 52-week high | -83.18% | -97.89% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +573.15% | +6107.84% |
| Average volume | 339.60K | 8.47M |
| Shares outstanding | 9.11M | 30.06M |
| Employees | 18 | 57 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Healthcare · Medical Devices · 18 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Healthcare · Medical Devices · 57 employees
NMTC vs VNRX FAQ
Which is bigger, NeuroOne Medical Technologies or VolitionRX?
NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $9.83M compared with $6.60M for VolitionRX (VNRX).
Are NeuroOne Medical Technologies and VolitionRX in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.